Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Yezan Munther Haddadin Insider Profile
4 Followers
Yezan Munther Haddadin, Director at Outlook Therapeutics, holds 5.05K shares in Outlook Therapeutics (Ticker: OTLK). Most recently, Yezan Munther Haddadin Bought $1,881 shares of Outlook Therapeutics on Mar 29, 2024 for an estimated value of 22.23K.
Yezan Munther Haddadin Outlook Therapeutics (OTLK)Director
Outlook Therapeutics (OTLK)
Director
Ranked #18,863 out of 99,335 Corporate Insiders
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
+17.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Yezan Munther Haddadin's holdings
Insider Roles
Director
Roles that Yezan Munther Haddadin holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 22, 2020 - Sep 22, 2021
Return:+234.40%
The most profitable trade made by Yezan Munther Haddadin
Yezan Munther Haddadin's Trading History
List of latest transactions for each holding click on a transaction to see Yezan Munther Haddadin's performance on stock
You May Also Like
Yezan Munther Haddadin insider profile FAQ
What is the percentage of profitable transactions made by Yezan Munther Haddadin?
The percentage of profitable transactions made by Yezan Munther Haddadin is 40%.
What is the average return per transaction made by Yezan Munther Haddadin?
The average return per transaction made by Yezan Munther Haddadin is 17.70%.
What stocks does Yezan Munther Haddadin hold?
Yezan Munther Haddadin holds: OTLK stocks.
What was Yezan Munther Haddadin’s latest transaction?
Yezan Munther Haddadin latest transaction was an Informative Buy of $22.23K.
What was Yezan Munther Haddadin's most profitable transaction?
Yezan Munther Haddadin’s most profitable transaction was an Informative Buy of OTLK stock on September 22, 2020. The return on the trade was 234.40%.
What is Yezan Munther Haddadin's role in Outlook Therapeutics?
Yezan Munther Haddadin's role in Outlook Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.